About BOTOX® for OAB

Targets the Source of OAB

BOTOX® Targets the Source of
Overactive Bladder (OAB)

BOTOX® takes a different approach from other medications

BOTOX® targets OAB at its source by being placed in the bladder without the need for surgery, weekly doctor visits, or daily OAB pills.*

*Anticholinergic.

X
021958_OAB Patient Animated Video_080924
Video Player is loading.
Current Time 0:00
Duration 15:18
Loaded: 0.00%
Stream Type LIVE
Remaining Time 15:18
 
1x
  • En-US
  • descriptions off, selected
  • captions off, selected
  • en (Main), selected

021958_OAB Patient Animated Video_080924

Transcript

Learn more about how BOTOX® works.

Expect more from your OAB treatment

Twice yearly BOTOX® treatment* gives you freedom from daily OAB pills that are intolerable or not working well enough.

*If OAB symptoms return before 6 months, talk to your doctor. A minimum of 12 weeks is needed between treatments.

Anticholinergic.

I thought my overactive bladder symptoms were just something I was going to have to live with somehow.”

— Marie

X
BOTOX OAB Patient Video (Marie)
Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected

      BOTOX OAB Patient Video (Marie)

      Transcript

      Hear why real patients started on BOTOX®.

      BOTOX® Reduces Daily Leakage Episodes

      BOTOX® could be an OAB treatment you’ve been searching for

      It is proven to work when other OAB medications did not

      BOTOX® can be used in adults who have an inadequate response to or are intolerant of an anticholinergic medication. BOTOX® was proven to reduce daily leakage episodes at week 12.

      Just 1 treatment significantly reduced daily leakage episodes

       

      BOTOX® was proven to significantly reduce daily leakage episodes after the first treatment

      In clinical trials, results were measured at 2, 6, and 12 weeks, with 12 weeks being the primary time point.

      In clinical trials,

      MONTHS AFTER TREATMENT

      People treated with BOTOX® had an average of

      FEWER LEAKAGE EPISODES PER DAY

      Compared to 1 fewer leakage episode per day with placebo

      You may notice results as soon as 2 weeks after treatment

      People who experienced a reduction in daily
      leakage episodes with BOTOX®

      3 months after treatment in clinical trials*:

       

      Limitation: The percentage of patients achieving 50% to 100% reduction in daily leakage episodes shown above was an additional measure in the primary clinical studies.

      *These results are based on an analysis of the primary clinical data (reduction in daily leakage episodes). No definitive conclusions about the treatment effects with BOTOX® can be drawn from these results.

      Study 1: BOTOX® n = 280, placebo n = 277;
      Study 2: BOTOX® n = 277, placebo n = 271:

      • Patients with ≥ 50% reduction: BOTOX® 57.5% and 63.5%; placebo 28.9% and 33.2%
      • Patients with ≥ 75% reduction: BOTOX® 44.6% and 47.3%; placebo 15.2% and 20.3%
      • Patients with 100% reduction: BOTOX® 22.9% and 31.4%; placebo 6.5% and 10.3%

      Approximately 1 in 4 people reported leakage episodes stopped completely

      Talk to your doctor about switching to BOTOX® or find a BOTOX® Specialist near you

      BOTOX® may positively impact your daily life by
      significantly reducing leakage episodes

      In BOTOX® clinical trials, a questionnaire showed:

      Patients reported improvement in their overall
      quality of life based on 3 categories*

      Avoiding situations and
      limiting behaviors

      Overplanning daily details, concern about bathroom accessibility, and limiting how much they drink

      Social and
      psychological impact

      Preoccupation with symptoms in everyday decisions, such as clothing and travel choices as well as their perceived overall well-being

      Social
      embarrassment

      Self-consciousness or worry that others may notice their symptoms

      Limitation: I-QOL was an additional measure in the primary clinical studies.

      *This improvement was reported using the Incontinence Quality of Life (I-QOL) questionnaire. This is a validated questionnaire that is used to measure the impact of urinary incontinence on a patient’s quality of life.

      Have more questions about BOTOX®?